GlassScriptPhysician profile
Emily Lasota
NPI 1215373550
$3,657.07
in general payments reported to CMS, 2019-2025
33 companies · $884 in 2025
The $884 reported for 2025 was more than what 89% of Obstetrics & Gynecology providers received nationally (typical 2025 total: $158).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $239 · 2020: $157 · 2021: $348 · 2022: $542 · 2023: $495 · 2024: $992 · 2025: $884.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $2,232 · Consulting Fee: $100 · Education: $40.05.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $2,231.79 |
| Consulting Fee | $100.00 |
| Education | $40.05 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbvie INC. | $497.83 | 2019-2025 | |
| Pfizer INC. | $451.52 | 2019-2025 | |
| Sumitomo Pharma America, INC. | $380.77 | 2023-2025 | Myfembree |
| Mayne Pharma Commercial LLC | $254.59 | 2022-2025 | |
| Astellas Pharma US INC | $224.96 | 2022-2025 | Veozah |
| Sage Therapeutics, LLC | $219.29 | 2023-2025 | Zurzuvae |
| Bayer Healthcare Pharmaceuticals INC. | $182.29 | 2020-2025 | |
| Organon LLC | $176.67 | 2022-2025 | Nexplanon, Jada System |
| Millicent US INC | $124.17 | 2024-2025 | Intrarosa, Femring |
| Allergan, INC. | $118.76 | 2019 | |
| Medtronic, INC. | $116.90 | 2025 | V-Loc 180 |
| Myovant Sciences INC. | $105.49 | 2021-2022 | |
| Hologic Sales and Service, LLC | $85.92 | 2020-2022 | |
| Therapeuticsmd, INC. | $81.84 | 2019-2021 | |
| Optumhealth Care Solutions, LLC | $63.69 | 2023-2025 | Eitan Medical, Vivify Health Care Team Portal 001, Zyno Solutions |
Show all 33 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Exeltis, USA INC. | $57.80 | 2023-2025 | Slynd |
| Avion Pharmaceuticals | $57.71 | 2020-2021 | |
| Mylan Pharmaceuticals INC. | $50.02 | 2020-2021 | |
| Agile Therapeutics, INC. | $47.73 | 2021-2023 | Twirla |
| Olympus America INC. | $45.52 | 2019 | |
| Coopersurgical, INC. | $39.79 | 2020-2022 | |
| Merck Sharp & Dohme LLC | $36.24 | 2020-2022 | |
| Smith+Nephew, INC. | $35.67 | 2025 | Pico |
| Aspira Women'S Health INC | $34.53 | 2024 | Ova1 |
| Laborie Medical Technologies Corp. | $29.79 | 2025 | Abby |
| Convatec INC. | $22.34 | 2025 | |
| Supernus Pharmaceuticals, INC. | $22.29 | 2025 | Qelbree |
| Exact Sciences Corporation | $19.08 | 2025 | The Cologuard Plus Collection Kit |
| Shield Therapeutics INC | $17.68 | 2024 | |
| Amag Pharmaceuticals, INC. | $14.89 | 2019 | |
| Salix Pharmaceuticals, A Division of Bausch Health US, LLC | $14.61 | 2024 | Xifaxan |
| Meditrina | $13.66 | 2024 | |
| Vertical Pharmaceuticals, LLC | $13.03 | 2020 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Emily Lasota listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.